ECO Animal Health Group (EAH) Share Price, News & Analysis

Company Overview

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline. Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide. Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.

Key Stats

• Today's Range: 93 to 98
• 50-Day Range: 72.04 to 99.85
• 52-Week Range: 50 to 100
• Volume: 98,325 shs
• Average Volume: 87,903 shs
• Market Capitalization: £64.01 million
• P/E Ratio: 3,903.05
• Dividend Yield: 0.94%
• Price Target: GBX 150
• Consensus Rating: Buy

EAH Stock Analysis - Frequently Asked Questions

How have EAH shares performed this year?

ECO Animal Health Group's stock was trading at GBX 67 at the beginning of the year. Since then, EAH stock has increased by 41.6% and is now trading at GBX 94.84.

How were ECO Animal Health Group's earnings last quarter?

ECO Animal Health Group plc (LON:EAH) announced its quarterly earnings data on Monday, July, 14th. The company reported $2.49 EPS for the quarter. ECO Animal Health Group had a trailing twelve-month return on equity of 1.27% and a net margin of 1.17%.

How do I buy shares of ECO Animal Health Group?

Shares of EAH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of ECO Animal Health Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that ECO Animal Health Group investors own include Intrepid Potash (IPI), Allena Pharmaceuticals (ALNA), Anpario (ANP), Iovance Biotherapeutics (IOVA), Navios Maritime (NM), Ampliphi Biosciences (APHB) and Actinium Pharmaceuticals (ATNM).

Company Calendar

• Last Earnings: 7/14/2025
• Today: 10/08/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: LON:EAH
• CIK: N/A
• Web: www.ecoanimalhealthgroupplc.com
• Phone: +44-20-83362900
• Fax: N/A
• Employees: 234
• Year Founded: N/A

Price Target and Rating

• Average Price Target for ECO Animal Health Group: GBX 150
• High Price Target: GBX 150
• Low Price Target: GBX 150
• Potential Upside/Downside: +58.2%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): GBX 0.02
• Trailing P/E Ratio: 3,903.05
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £1.05 million
• Net Margins: 1.17%
• Pretax Margin: N/A
• Return on Equity: 1.27%
• Return on Assets: 2.14%

Debt

• Debt-to-Equity Ratio: 4.81
• Current Ratio: 2.96
• Quick Ratio: 2.14

Sales & Book Value

• Annual Sales: £79.60 million
• Price / Sales: 0.80
• Cash Flow: GBX 15.67 per share
• Price / Cash Flow: 6.05
• Book Value: GBX 137.84 per share
• Price / Book: 0.69

Miscellaneous

• Outstanding Shares: 67,490,000
• Free Float: N/A
• Market Cap: £64.01 million
• Optionable: Not Optionable
• Beta: -0.05